glp-1 weight loss drug news today 2025 Agonists Drugs Market Report, 2025-2030 Poll: 1 in 8 Adults

Hypersensitivity Reactions: Serious hypersensitivity reactions (e.g., anaphylaxis and angioedema) have been reported during postmarketing use of liraglutide

R., Wefers, J., & Meier, J

For the primary study outcome gestational weight gain 488 GLP-1-exposed pregnancies (people receiving at least one GLP-1 medication between 3 years before and 90 days after pregnancy) were propensity-score matched with 1,344 unexposed pregnancies

Data availability All data generated or analyzed during this meta-analysis are derived from peer-reviewed publications, as detailed in the references

But supplements may rely on preliminary or incomplete data, so its less clear what effect they will have on you

[DOI] [PMC free article] [PubMed] [Google Scholar] 5.Lecis D, Prandi FR, Barone L, et al